• Event Date
  • October 28-30, 2022
  • Event Location
  • Osaka, Japan
The organizing committee decided to postpone WCF-2021 due to the current Covid-19 status in Japan. Further data information please visit https://www.mhlw.go.jp/english/.
Event date is to be confirmed.
Speakers who are interested in WCF-2023 in Budapest https://www.istci.org/wcf2023/index.asp please contact us via johanna@istci.org for more information.
Program of Medicinal Chemistry
 

 

Day 1: October 28, 2022 (Friday)

Plenary Forum (I)

 

Time: 09:10-12:10, October 28, 2022 (Friday); Place: Osaka, Japan 

 

Moderator:

Dr. Yusuke Yamauchi, Professor, The University of Queensland, Australia

09:10-09:40

Title: Multifunctional Synergy for Enhancing Materials Performance

Dr. Shi Xue Dou, Distinguished Professor, University of Wollongong, Australia

09:40-10:10

Title: Functionalized Fluoride Materials for Photonics, Energy, and Sustainable Issues

Dr. Alain Tressaud, CNRS Emeritus Research Director, ICMCB, University Bordeaux, France, and Vice-President, European Academy of Sciences, Brussels, Belgium

10:10-10:40

Title: New Strategies for Addressing the Issue of Waste Plastics
Dr. Yu-Zhong Wang, Professor, Sichuan University, China

10:40-11:10

Title: Nanosciences, Biological Imaging and Renewable Energy

Dr. Hongjie Dai, Professor, Stanford University, USA

11:10-11:40

Title: Carbon-based Nanomaterials for Various Applications

Dr. Michael Giersig, Professor, Free University of Berlin, Germany

11:40-12:10

Title: The Nanomaterials Design and Processing for Electrodes of Metal Ion Batteries

Dr. Hua Kun Liu, Distinguished Professor, University of Wollongong, Australia

 

Forum 4-1: Drug Discovery and Development

Time: 13:30-17:10, October 28, 2022 (Friday); Place: Osaka, Japan

Chair

Dr. Wingfield Jonathan, Principal Scientist, AstraZeneca, UK

Co-Chair

Dr. Xiaobo Mao, Assistant Professor, The Johns Hopkins University School of Medicine, USA

13:30-13:55

Title: Development of Acoustic Sample Loading for Mass Spectrometry and Chemistry Applications

Dr. Jonathan Wingfield, Principal Scientist, AstraZeneca, UK

13:55-14:20

Title: TBD

Dr. Kausik K. Nanda, Pharmaceutical Scientist, Merck, USA

14:20-14:45

Title: Cytokinin Derivatives, Their Antisenescent Activity, UVA and UVB Photoprotectivity and Prevention of Oxidative Stress
Dr. Lucie Plíhalová, Associate Professor, Palacký University in Olomouc, Czech Republic

14:45-15:10

Title: Molecular Mechanism of Pathologic Prion-like Proteins Transmission and Neurotoxicity
Dr. Xiaobo Mao, Assistant Professor, The Johns Hopkins University School of Medicine, USA

15:10-15:30

Coffee Break

15:30-15:55

Speech Opportunity Available

15:55-16:20

Title: Development of Radiolabelled Glucosamine and a Core-peptide for Diagnostic Imaging of Arthritis

Dr. Vijay Kumar, Professor, University of Sydney, Australia

16:20-16:45

Title: New Spiro Compounds and DNA End-joining Inhibition
Dr. K. S. Rangappa, Professor, University of Mysore, India

16:45-17:10

Title: Discovery of Hsp70-Bim Complex as a New Drug Target for CML by Using Activity-based Probes

Dr. Ting Song, Associate Professor, Dalian University of Technology, China

 

 

 

Day 2: October 29, 2022 (Saturday)

 

Forum  4-2: Drug Formulation and Drug Delivery

Time: 08:30-12:10, October 29, 2022 (Saturday); Place: Osaka, Japan

Chair

Call for Chair

Co-Chair

Call for Co-Chair

08:30-08:55

Title: From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs)

Dr. Thurston David, Professor, King's College London, UK

08:55-09:20

Title: Spray- Freeze Drying as a New Platform for the Formulation of Precision Medicine

Dr. Hans Leuenberger, Professor, University of Basel, Switzerland

09:20-09:45

Speech Opportunity Available

09:45-10:10

Title: Phospholipid Ether Monomers as Targeted Drug Delivery Vehicles for Cancer

Dr. Jarrod Longcor, Chief Business Officer, Cellectar Biosciences, USA

10:10-10:30

Speech Opportunity Available

10:30-10:55

Title: Plant Virus Nanoparticles to Improve Global Health

Dr. Kathleen Laura Hefferon, Post Doctoral Associate, Cornell University, USA

10:55-11:20

Title: Stable Injectable Formulation for Sustained Release Delivery of Leuprolide for the Treatment of Advanced Prostate Cancer

Dr. Yuhua Li, Vice President, Foresee Pharmaceuticals, Inc, Taiwan

11:20-11:45

Title: Antitumor Effects of Fisetin and Fisetin Micelles on Ovarian Cancer in Vitro and in Vivo

Dr. Xue Xiao, West China Medical College of Sichuan University, China

11:45-12:10

Title: Advances in Multiple Myeloma Therapy during Two Past Decades

Dr. Ivan Spicka, Assistant Professor, Charles University and General Teaching Hospital, Czech Republic

 

Day 3: October 30, 2022 (Sunday)

 

Forum 4-3: Drug Design and Synthesis

Time: 08:30-12:10, October 30, 2022 (Sunday); Place: Osaka, Japan

Chair

Call for Chair

Co-Chair

Call for Co-Chair

08:30-08:55

Speech Opportunity Available

08:55-09:20

Speech Opportunity Available

09:20-09:45

Title: TBD

Dr. Pascale Gauthier, Pharmacist, University of Clermont Auvergne, France

09:45-10:10

Title: Recent Discoveries in HIV-1 Reverse Transcriptase Inhibitors

Dr. Shuang-Xi Gu, Professor, Wuhan Institute of Technology, China

10:10-10:30

Coffee Break

10:30-10:55

Speech Opportunity Available

10:55-11:20

Title: Design of Biologically Active Coordination Compounds with Pyromucic Acid
Dr. Irina Lutsenko, Assistant professor, N.S. Kurnakov Institute of General and Inorganic Chemistry, Russia

11:20-11:45

Title: Tuning Anticancer Function of Small Molecule Drugs Through Aptamer Modification

Dr. Xue-Qiang Wang, Professor, Hunan University, China

11:45-12:10

Title: Study of The Target Delivery Process of Peptide Modified Liposomes to Solid Tumors

Dr. Hailing Tang, Associate Professor, Guangxi University of Chinese Medicine, China

 

 

 

 

 

Latest News

• Online Registration is Open
July 1st, 2019

• Call for speakers!
July 1st, 2019

• Welcome to the website of WCF-2021
June 20th, 2019

Important Dates

• Abstract Submission Start Day
July 1st, 2019

• Earlybird Registration Start Day
July 1st, 2019

• Earlybird Registration Deadline
Sep. 30th, 2019

• Abstract Submission Deadline
August 31st, 2022

• Acceptance Notification Deadline
August 20th, 2022

Copyright© 2019-2021 ISTCI.ORG All Rights Reserved.